Bookmark
Forward
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
Lancet (London, England) 2023 Jan 07Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Thomas Mulliez, Mark De Ridder. Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? Lancet (London, England). 2023 Jan 07;401(10370):23-24
Mesh Tags
PMID: 36610767
View Full Text
